<DOC>
	<DOCNO>NCT01557088</DOCNO>
	<brief_summary>The majority acute coronary event cause coronary artery segment minimal luminal disease , potentially significant vascular wall inflammation oxidative stress lead plaque vulnerability . It become apparent initial injury endothelial surface , primary site mechanism involve role vascular inflammation interaction oxidative stress continue emerge . Lipoprotein-associated phospholipase A2 ( Lp-PLA2 ) novel biomarker vascular wall inflammation circulates blood bound low density ( LDL ) high density ( HDL ) lipoprotein promote vascular inflammation . Circulating level Lp-PLA2 mass activity independent risk factor cardiovascular event . Recent study , demonstrate Lp-PLA2 also associate coronary endothelial dysfunction . However , relationship Lp-PLA2 early atherosclerotic change coronary artery , contribution lipoprotein bind deleterious potential Lp- PLA2 elucidate . Our work hypothesis endogenous local activation Lp-PLA2 pathway play integral role early coronary atherosclerosis contributes mechanism coronary endothelial dysfunction structural mechanical property reflect plaque vulnerability . Thus , current application characterize prospectively correlation functional , mechanical , structural vascular wall property , systemic well coronary activity Lp-PLA2 pathway .</brief_summary>
	<brief_title>Lp-PLA2 Coronary Atherosclerosis Humans</brief_title>
	<detailed_description>Aim I : Hypothesis : The extent endothelial dysfunction correlate production Lp-PLA2 oxidative stress correlate tissue characteristic plaque vulnerability . The investigator define systemic coronary gradient production marker inflammation oxidative stress presence coronary endothelial dysfunction patient early coronary atherosclerosis . Aim II : Hypothesis : The distribution Lp-PLA2 LDL associate great coronary endothelial dysfunction correlate degree coronary atherosclerosis plaque vulnerability . The investigator define distribution Lp-PLA2 patient early coronary atherosclerosis endothelial dysfunction .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Patients undergo coronary angiography include endothelial function test male female age 18 age 85 Heart failure ejection fraction le 40 % unstable angina myocardial infarction angioplasty within 6 month prior entry study use investigational agent within 1 month entry study patient require treatment positive inotropic agent digoxin study patient cerebrovascular accident within 6 month prior entry study significant endocrine , hepatic renal disorder local systemic infectious disease within 4 week prior entry study pregnancy lactation ( woman childbearing age pregnancy test prior angiogram ) mental instability federal medical center inmates hemoglobin less 12 mg/dL severe asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>coronary artery spasm</keyword>
	<keyword>small vessel coronary artery disease</keyword>
</DOC>